AtriCure (ATRC) Reports Q2 Loss of $0.11, Beats by 6c; Reaffirms FY08 Guidance
Tweet Send to a Friend
AtriCure, Inc. (Nasdaq: ATRC) reports a Q2 loss of $0.11, 6 cents better than the analyst estimate of ($0.17) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
